)
InnoCan Pharma (INNO) investor relations material
InnoCan Pharma Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Reported revenue of US $5.25 million for Q2 2026, a 25.06% decrease year-over-year.
Gross margin remained strong at 90.8% despite lower sales.
Operating loss increased to US $0.508 million, up 228.3% year-over-year.
Flagship skincare brand VALITIC™ maintained Amazon Best Seller and Amazon's Choice status, reflecting strong consumer demand.
BI Sky subsidiary is expanding sales channels beyond Amazon, including direct-to-consumer and major retail networks.
Financial highlights
Q2 2026 revenue: US $5.25 million, down 25.06% from Q2 2025.
Gross profit: US $4.769 million, down 23.0% year-over-year.
Gross margin: 90.8% in Q2 2026, up from 88.4% in Q2 2025.
Operating loss: US $0.508 million, compared to a smaller loss in Q2 2025.
Cash and cash equivalents: US $6.4 million as of June 30, 2026.
Outlook and guidance
Initiatives underway to diversify sales channels and expand market reach.
Focus on leveraging established brands and customer base for future growth.
Expectation of revenue growth and increased brand visibility over the coming year.
- Q1 2026 revenue rose 29.7% sequentially to $6.47M, with gross margin at 91.1%.INNO
Q1 2026 - Q2 2024 revenue up 177% year-over-year, net profit turns positive, driven by BI Sky Global.INNO
Q2 2024 - Revenue and profit soared year-over-year, led by new products and robust online sales.INNO
Q3 2024 - Revenue more than doubled in 2024, driven by BI Sky Global's strong sales performance.INNO
Q4 2024 - Operating profit rebounded in H1 2025 as LPT-CBD platform advanced and Nasdaq listing pursued.INNO
Q1 2025 - Operating profit turned positive in H1 2025 amid revenue decline and Nasdaq listing plans.INNO
Q2 2025 - 2025 revenues fell 9.6% to US $26.6M, but gross margin stayed high at 89.9%.INNO
Q4 2025 - Revenue fell 10% to $21.6M, but gross margin stayed high at 90.2% amid ongoing R&D progress.INNO
Q3 2025
Next InnoCan Pharma earnings date
Next InnoCan Pharma earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage